Compounds > 6,15-diketo-13,14-dihydroprostaglandin f1alpha
Page last updated: 2024-09-05

6,15-diketo-13,14-dihydroprostaglandin f1alpha and nafazatrom

6,15-diketo-13,14-dihydroprostaglandin f1alpha has been researched along with nafazatrom in 1 studies

Compound Research Comparison

Studies
(6,15-diketo-13,14-dihydroprostaglandin f1alpha)		Trials
(6,15-diketo-13,14-dihydroprostaglandin f1alpha)		Recent Studies (post-2010)
(6,15-diketo-13,14-dihydroprostaglandin f1alpha)		Studies
(nafazatrom)		Trials
(nafazatrom)		Recent Studies (post-2010) (nafazatrom)
11009250

Protein Interaction Comparison

ProteinTaxonomy6,15-diketo-13,14-dihydroprostaglandin f1alpha (IC50)nafazatrom (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)6.1667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myatt, L; Williams, HJ; Young, KD1

Other Studies

1 other study(ies) available for 6,15-diketo-13,14-dihydroprostaglandin f1alpha and nafazatrom

ArticleYear
Thrombotic thrombocytopenic purpura: treatment with nafazatrom.
    Clinical and laboratory haematology, 1984, Volume: 6, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Epoprostenol; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones

1984